Skip to content

Does Position Influence the Diagnosis of Detrusor Overactivity in a Neurological Population

Does Position Influence the Diagnosis of Detrusor Overactivity in a Neurological Population - a Concordance Study Between Lying and Sitting Position

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05949567
Acronym
Cysto-position
Enrollment
160
Registered
2023-07-18
Start date
2024-04-02
Completion date
2027-04-02
Last updated
2026-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurologic Disorder, Urodynamic Exam

Keywords

Urodynamic exam, detrusor overactivity, positon

Brief summary

ICS (International Continence Society) recommendations published in 2017 recommend performing urodynamic examinations in the sitting or standing position. These recommendations are based on a review of the literature published in 2008, which has several limitations: heterogeneous populations, old and non-harmonized techniques, and very few neurological patients. It seems appropriate to focus on neurological patients and to examine the influence of position on the detection of detrusor overactivity in these patients. The point here is to reexamine the ICS recommendations, which are not designed for neurological patients. Indeed, many patients suffering from Multiple Sclerosis (MS) or Parkinson's disease are unable to sit or stand for the duration of the urodynamic examination. The investigators would like to assess whether exploring sphincter disorders in the supine position is still interpretable. This would enable us to define ICS good practice recommendations for a neurological population.

Detailed description

1st consultation (selection - D-15): * Targeted questioning of disorders, completion of USP self-questionnaire, and UPDRS or EDSS scales as part of care. * Verification of ultrasound results (for men). * Schedule Urodynamic Assessment as part of treatment. * Verification of eligibility criteria * Partial information of the patient (or relative/guardian/guardian if applicable) to limit bias, and a period of reflection prior to the urodynamic test to collect consent. On the day of the Urodynamic Assessment (D0): * Written, free and informed consent. * Data collection by a physician trained in the study, * Randomization of patient to determine starting position (lying or sitting) for urodynamic assessment (via CleanWeb). * Urodynamic assessment according to ICS recommendations, with constant filling speed over the 2 fillings (50 ml/min), water filling - Laborie machine - T-Doc system in both positions in the order defined by randomization, and printout of curves. * Entry of socio-demographic data. * Curves reread by a doctor who had not performed the examination and who did not know the patient or the starting position (single blind). * Completion of the paper file by the physician reading the curves, with the following data for position 1 and position 2: * Volume at B1 and B3 (in ml) * Basal bladder pressure (cm / H2O) * Occurrence of CNID or mictional reflex arc (diagnosis of detrusor overactivity) * Volume of leakage or 1st NIDC (Uninhibited Detrusor Contraction) (ml) or * Bladder pressure at leakage (cm / H2O) * Maximum bladder pressure (cm / H2O) * Paper data entry on Excel database by a trained investigator declared on the study

Interventions

OTHERurodynamic exam in sitting and lying position

Urodynamic exam with 1st filling in sitting or lying position. Then , during the same procedure, a second filling in the opposite position of the 1st filling (lying or sitting)

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with MS or neurologically confirmed Parkinson's disease, with indication for urodynamic assessment - 1st assessment * Clinical overactive bladder syndrome with USP overactive bladder sub-score \> or = 4 - Age ≥18 years * In men: no prostatic hypertrophy on ultrasonography * In women: no stress urinary incontinence (SUI); USP SUI subscore ≤ 2 * Affiliated with a social security scheme (excluding AME). * Free and informed written consent

Exclusion criteria

* Opposition to the performance of a Urodynamic exam as part of treatment

Design outcomes

Primary

MeasureTime frameDescription
concordance diagnosis of detrusor overactivity between lying and sitting position24 monthsMeasurement concordance of detrusor pressures using the intraclass correlation coefficient statistic

Secondary

MeasureTime frameDescription
position influence on the overactive detrusor gravity between the 2 positions24 monthsMeasurement of the concordance of detrusor overactivity diagnostic gravities during urodynamic assessments, between those performed in the supine position and those performed in the seated position. Concordance will be assessed using Cohen's Kappa statistic.
Evaluation of the diagnosis quality of the detrusor overactivity between the 2 position24 monthsMeasurement of the diagnostic quality of urodynamic testing performed in the supine position in neurological patients to detect detrusor activity, with the seated position being the gold standard: estimation of sensitivity and specificity.
comparison of the distribution of detrusor overactivity diagnoses according to position.24 monthsMeasurement of the association between position during urodynamic assessment and diagnosis of detrusor overactivity: comparison of the distribution of diagnoses of detrusor overactivity according to position.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 18, 2026